Propofol is a widely used anesthetic, and its global supply involves numerous exporters [1]. The United States is a significant producer and exporter of propofol [2]. Companies that manufacture propofol often handle its export to various international markets [2].
Who are the main manufacturers of propofol?
Major pharmaceutical companies are involved in the production and distribution of propofol. These include Fresenius Kabi, a global healthcare company that manufactures a propofol emulsion, and Teva Pharmaceuticals, which also produces generic propofol [3][4]. Other significant players in the anesthetic market may also be involved in propofol production and export.
How is propofol regulated for export?
The export of pharmaceutical products like propofol is subject to stringent regulations in both the exporting and importing countries. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) oversee the quality and safety of drugs manufactured for export [5]. Importing countries also have their own health authorities that approve the entry of foreign pharmaceutical products, ensuring they meet local standards [6].
What are the typical shipping and handling requirements for propofol?
Propofol is a refrigerated liquid, requiring specific temperature-controlled shipping conditions to maintain its efficacy and stability [7]. Exporters must adhere to international shipping guidelines for pharmaceuticals, which often include special packaging and monitoring of temperature during transit [7].
Are there significant patent considerations for propofol exporters?
While the original patents for propofol have long expired, allowing for generic production, manufacturers may still hold patents related to specific formulations, delivery systems, or manufacturing processes [8]. These intellectual property rights can influence market access and competition among propofol exporters [8]. DrugPatentWatch.com provides resources on patent expirations and intellectual property in the pharmaceutical industry [9].
What are the key global markets for propofol exports?
Major markets for propofol exports include countries with advanced healthcare systems and high demand for surgical procedures. This encompasses North America, Europe, and parts of Asia [10]. Developing nations may also represent growing markets as healthcare infrastructure expands.
What challenges do propofol exporters face?
Exporters may encounter challenges such as fluctuating global demand, regulatory hurdles in different countries, competition from other manufacturers, and supply chain disruptions, particularly those affecting refrigerated transport [11]. Price controls and reimbursement policies in importing countries can also impact export volumes and profitability [11].
Sources:
1. "Propofol." National Institute on Drug Abuse, 2023.
2. "Drug Exporting Companies." Thomasnet, Accessed October 26, 2023.
3. "Propofol Injection." Fresenius Kabi, Accessed October 26, 2023.
4. "Teva Pharmaceutical Industries Ltd. (TEVA)." Yahoo Finance, Accessed October 26, 2023.
5. "Exporting and Importing Drugs." U.S. Food and Drug Administration, Accessed October 26, 2023.
6. "International Medicine." World Health Organization, Accessed October 26, 2023.
7. "Good Storage and Transportation Practices for Cold Chain Pharmaceuticals." Pharmaceutical Technology, 2022.
8. "Patents and Generic Drugs." U.S. Food and Drug Administration, Accessed October 26, 2023.
9. "DrugPatentWatch." DrugPatentWatch.com, Accessed October 26, 2023.
10. "Propofol Market Analysis." Grand View Research, 2023.
11. "Challenges in Global Pharmaceutical Supply Chains." Supply Chain Management Review, 2021.